News Releases

2012

XXX
Dec.19.2012
Phase III Trial of L-BLP25 (Stimuvax®) in Patients with Non-Small Cell Lung Cancer Did not Meet Primary Endpoint (43.7KB)
XXX
Nov.05.2012
Announcement on Financial Results for FY2012 2Q
XXX
Oct.23.2012
Ono Enters into Collaboration Agreement with Domain Therapeutics in the Field of GPCR-Based Drug Discovery (57.0KB)
XXX
Oct.04.2012
Ono Conducts the Nation's First Microdosing Study Using Its Novel and Innovative Drug Candidate (31.9KB)
XXX
Sep.28.2012
Announcement on Annual Report 2012
XXX
Sep.03.2012
Ono and Galapagos Subsidiary BioFocus Sign Drug Discovery Agreement in the Field of CNS Disorders (74KB)
XXX
Aug.02.2012
Announcement on Financial Results for FY2012 1Q
XXX
Jul.23.2012
Carfilzomib, a proteasome inhibitor, has been granted FDA accelerated approval (101KB)
XXX
Jul.10.2012
Bristol-Myers K.K. Files for Regulatory Approval in Japan for ORENCIA® Subcutaneous Injection (abatacept [rDNA]), Rheumatoid Arthritis Agent (61.2KB)
XXX
Jul.02.2012
Clinical Trial Application submitted for Phase I study of ONO-7268MX1, peptide-cocktail vaccine for hepatocellular carcinoma (13.7KB)
XXX
Jun.22.2012
Approval for Additional Indication of "EMEND® Capsule", an Antiemetic Selective Neurokinin-1 (NK1) Receptor Antagonist, for Pediatric Patients Aged 12 and older (23.1KB)
XXX
Jun.21.2012
Voting result on Carfilzomib at FDA Oncologic Drug Advisory Committee (83.2KB)
XXX
Jun.08.2012
Announcement on Appointment of Corporate Officer (41.7KB)
XXX
Jun.04.2012
Fully Human Anti-PD-1 Antibody "ONO-4538/BMS-936558" Results from Phase 1 Study in Cancer Patients Published in New England Journal of Medicine (NEJM) and Presented at Annual Meeting of the American Society of Clinical Oncology (ASCO) (94.2KB)
XXX
May.30.2012
Ono and Galapagos Subsidiary BioFocus Sign an Additional Target Discovery Agreement in the Field of Allergic Disease (106KB)
XXX
May.15.2012
Ono Enters into Drug Discovery Collaboraition with Scil Proteins for Affilin® Therapeutics (61.0KB)
XXX
May.14.2012
Results of PhaseUStudy of ONO-2745/CNS 7056, a Short-acting General Anesthetic (19.5KB)
XXX
May.9.2012
Announcement on Financial Results for FY2011
XXX
Apr.23.2012
Revisions of Consoldated Financial Forecasts (39.7KB)
XXX
Apr.17.2012
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients (20.2KB)